Grants and Contributions:
Title:
Development of a 3D muscle microtissue device for high-throughput drug screening
Agreement Number:
956436
Agreement Value:
$99,986.00
Agreement Date:
Oct 5, 2020 - Mar 31, 2023
Description:
The project aims at developing a high throughput assay and device to harness the potential of 3D skeletal muscle cell culture in life sciences application.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H4E 1A8
Reference Number:
172-2020-2021-Q2-956436
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
783694524
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 243 days. The total amended value is 29,674 dollars.
Amendment Date
Jul 4, 2022
Recipient's Operating Name:
Développement eNuvio
Recipient's Legal Name:
eNuvio Inc.
Federal Riding Name:
LaSalle--Émard--Verdun
Federal Riding Number:
24037
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: